Somnigroup International has printed its Q2 results and the market's verdict was swift: the stock fell 6.2% on August 6, confirming the cautious pre-earnings positioning documented in last week's note, and the Street has responded by marking down targets across the board while keeping bullish ratings intact.
The analyst reaction post-print tells a consistent story. Three firms lowered price targets on August 7 — UBS cut from $105 to $94, Piper Sandler from $102 to $95, and Truist Securities from $115 to $100 — all while maintaining Buy or Overweight ratings. That pattern, targets down but convictions held, signals analysts believe the quarter was a disappointment on numbers rather than thesis. The consensus mean target now sits around $90.56, against a closing price of $65.25, which implies roughly 39% upside. Morgan Stanley's July 27 initiation at Overweight with a $95 target — flagged in last week's preview — now sits comfortably within the pack rather than as an outlier, reinforcing that the bull community remains intact even as near-term estimates come in. The bear case focuses on sluggish housing turnover, mortgage rate pressure on bedding demand, and input cost exposure via crude oil derivatives. Bulls counter with supply chain strength and the longer-term earnings recovery path tied to the Leggett & Platt acquisition.
Short positioning has barely moved through the earnings event, which is itself notable. Short interest eased slightly to 6.87% of the free float — down just under 22% from its late-June peak above 9%, a move that was already well underway before the print. The lending market remains loose: availability is running at 365%, well above the 52-week low of 173%, and cost to borrow has ticked up modestly this week to 0.64%, still firmly in low-cost territory. There is no evidence of a post-earnings short rebuild. The ORTEX short score has drifted marginally lower over the past week, from around 56 to 55.3, consistent with a positioning picture that is neither intensifying nor unwinding in any dramatic way.
Options traders remain notably call-heavy even after the selloff. The put/call ratio held near 0.13 on Friday — barely above its 20-day average of 0.13 and far below the 52-week high of 0.62. Investors are still not reaching for downside protection in any meaningful volume. That callside skew, combined with the absence of a short rebuild, suggests the market is treating the earnings drop as a reset rather than a deterioration.
The peer divergence sharpened this week. MHK gained more than 10%, TOL added 6.3%, and IBP climbed 9.5%, while SGI barely moved — down 0.1% on the week. Housing-adjacent names are clearly catching a bid from the broader consumer and homebuilder recovery that SGI has not shared. The factor score picture captures the tension: analyst recommendation differential ranks in the 99th percentile of the ORTEX universe, reflecting unusually strong analyst conviction relative to peers, while the short score rank sits at just the 13th percentile, meaning the stock is less shorted than 87% of comparable names — a setup that removes one traditional recovery catalyst.
The next earnings event is scheduled for November 5, giving the housing cycle three months to either validate or challenge the Street's recovery thesis. Until then, the key read will be whether monthly housing data — particularly existing home sales and mortgage application volumes — shows any acceleration, given how directly that feeds the bull case on bedding demand.
See the live data behind this article on ORTEX.
Open SGI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
